Patricia
Aspichueta Celaá
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (40)
2024
-
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology, Vol. 79, Núm. 1, pp. 135-148
-
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597
2023
-
Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS−/− mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
NMR in Biomedicine, Vol. 36, Núm. 8
-
Expanding the roles of the renin–angiotensin system: Drug-induced liver injury
Journal of Hepatology
-
Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting
Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8
-
In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice
Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 15-26
-
In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice
Methods in molecular biology (Clifton, N.J.), Vol. 2675, pp. 1-13
-
Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD
Metabolism: Clinical and Experimental, Vol. 145
-
miR-21p-5p coordinates biological pathways to promote MASLD progression
Liver International
2022
-
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
Hepatology, Vol. 76, Núm. 6, pp. 1617-1633
-
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease
Nature Reviews Gastroenterology and Hepatology, Vol. 19, Núm. 9, pp. 585-604
-
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24
-
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis
Nature Communications, Vol. 13, Núm. 1
-
Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD
Antioxidants, Vol. 11, Núm. 11
-
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Journal of Hepatology, Vol. 77, Núm. 4, pp. 991-1004
-
Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity
Cancers, Vol. 14, Núm. 19
-
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
Journal of Hepatology, Vol. 77, Núm. 1, pp. 177-190
2021
-
A uhplc-mass spectrometry view of human melanocytic cells uncovers potential lipid biomarkers of melanoma
International Journal of Molecular Sciences, Vol. 22, Núm. 21
-
E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment
Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887
-
Fat: Quality, or quantity? what matters most for the progression of metabolic associated fatty liver disease (mafld)
Biomedicines, Vol. 9, Núm. 10